Sodium Sulfacetamide, Sulfur
NDC 44523-612
Product Information
Sodium Sulfacetamide, Sulfur is a UNAPPROVED DRUG OTHER-approved product labeled by Biocomp Pharma, Inc.. This product is primarily utilized in pharmaceutical processing or compounding. It is supplied as a yellow product. This product entry covers the primary NDC 44523-612 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Labeler & Regulatory Data
Marketing Timeline
Product Characteristics
Code Structure Chart
Product Details
What is NDC 44523-612?
What are the uses of this product?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- SULFUR (UNII: 70FD1KFU70)
- SULFUR (UNII: 70FD1KFU70) (Active Moiety)
- SULFACETAMIDE SODIUM (UNII: 4NRT660KJQ)
- SULFACETAMIDE (UNII: 4965G3J0F5) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- SODIUM LAURYL SULFATE (UNII: 368GB5141J)
- WATER (UNII: 059QF0KO0R)
- SODIUM ALUMINIUM SILICATE (UNII: 058TS43PSM)
- GLYCERYL MONOSTEARATE (UNII: 230OU9XXE4)
- PEG-100 STEARATE (UNII: YD01N1999R)
- PHENOXYETHANOL (UNII: HIE492ZZ3T)
- PROPYLENE GLYCOL (UNII: 6DC9Q167V3)
- CETYL ALCOHOL (UNII: 936JST6JCN)
- LAPONITE (UNII: D703131383)
- SODIUM THIOSULFATE (UNII: HX1032V43M)
- STEARYL ALCOHOL (UNII: 2KR89I4H1Y)
- XANTHAN GUM (UNII: TTV12P4NEE)
- BENZYL ALCOHOL (UNII: LKG8494WBH)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 1000946 - sulfacetamide sodium 10 % / sulfur 4 % Medicated Pad
- RxCUI: 1000946 - sulfacetamide sodium 100 MG/ML / sulfur 40 MG/ML Medicated Pad
- RxCUI: 1000946 - sulfacetamide sodium 10 % / sulfur 4 % Topical Swab
* Please review the full disclaimer at the bottom of this page.